Disclosures for "Chlorovirus Glycoproteins and SOD1G93A Significantly Enhance, While Cellular Proteins IRF3 and ERK MAP-kinase Significantly Dampen, Production of ALS-associated Inflammatory Factors from Murine Macrophages"
-
The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
-
Tom Petro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Tom Petro has received research support from Stuart Nichols ALS fund.
-
Dr. Esmael has nothing to disclose.
-
Irina Agarkova has nothing to disclose.
-
The institution of David Dunigan has received research support from University of Nebraska.
-
Dr. Chiodo has nothing to disclose.
-
Prof. De Castro has nothing to disclose.
-
James Van Etten has nothing to disclose.